QT
IART icon

Quantamental Technologies’s Integra LifeSciences IART Stock Holding History

Quantamental Technologies’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,855
Closed -$405K – 434
2023
Q2 		$405K Buy
+9,855
New +$474K 0.17% 204
2019
Q4 		– Sell
-2,508
Closed -$151K – 841
2019
Q3 		$151K Buy
+2,508
New +$149K 0.05% 588
2019
Q1 		– Sell
-3,832
Closed -$173K – 1619
2018
Q4 		$173K Buy
+3,832
New +$210K 0.1% 352

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantamental Technologies's IART Position: Q3 2023 in Review

Quantamental Technologies sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 9,855 shares — an estimated $405K sold.

Quantamental Technologies first reported a position in IART in Q4 2018 and held it in 3 quarters. The position peaked at $405K in Q2 2023. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

  • Quantamental Technologies reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 9,855 Integra LifeSciences shares in Q3 2023, an estimated $405K.
  • Quantamental Technologies first reported a position in Integra LifeSciences in Q4 2018 and held it in 3 quarters.
  • Quantamental Technologies's Integra LifeSciences position peaked at $405K in Q2 2023.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.